Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential determination of effective ciprofol + remifentanil dose for laryngeal mask placement
ChiCTR2200062686Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol and remifentanil, sponsored by Ruijin Hospital. Primary endpoints: Electroencephalogram monitoring, Heart rate and 3 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ciprofolremifentanil
Beyond the preview
Go deeper on ChiCTR2200062686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062686.